Lifestyle program to help people with MPN move more
Part of Blood & lymphatic, Cancer clinical trials.
This pilot study tests a lifestyle and movement program for adults with certain myeloproliferative neoplasms (MPNs), aiming to improve well-being through safe exercise habits. You may be considered if you have an MPN and at least one heart-related risk factor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older
- You have an MPN diagnosis (like essential thrombocythemia, polycythemia vera, pre-fibrotic myelofibrosis, myelofibrosis, or MPN not otherwise specified)
- If you have myelofibrosis, your risk level must be low or intermediate-1 (not intermediate-2 or high)
- Your activity level is good (ECOG 0–1) and not very limited (not ECOG 3–4)
- You have at least one cardiovascular (heart) risk factor, such as higher body weight, blood pressure, high cholesterol, diabetes or pre-diabetes, metabolic syndrome, or a past heart/brain/blood vessel problem
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help people who have survived a blood cancer stay healthier as they age. It involves exercise and check-ups to see if we can slow down some effects of aging.
This trial is testing a digital lifestyle app designed to help people with myeloproliferative neoplasms (MPNs) manage their health and wellness. By using the app, you may get support in tracking symptoms, lifestyle habits, and connecting with resources that could improve your quality of life.
This study tests whether a regular exercise program can improve health and well-being for people with myeloproliferative neoplasms (a group of blood cancers). It is designed to help you feel stronger and manage your condition better.
This study tests a lifestyle program that includes physical activity and nutrition guidance for people who have had multiple myeloma for at least a year. The goal is to see if this program helps improve quality of life and overall well-being.
This study tests whether a personalized exercise program can help reduce fatigue in people with certain blood cancers, like myeloproliferative neoplasms or chronic myeloid leukemia. If you have been feeling tired and are stable on your treatment, this might help you feel better.
This trial tests whether exercise is safe and feasible for people with low-risk myeloid cancers or certain bone marrow conditions. It aims to see if a supervised exercise program can be done without problems.
Hear when a new Myeloproliferative Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.